changing your setting. We'll assume that you are happy to receive all cookies on the BTG website.
Certain BTG products may not be available within the chosen location and indications may differ from your country's approved use.
For Medical questions regarding any BTG products, please contact email@example.com
PneumRx<sup>®</sup> Coils are indicated for use in patients with homogeneous and/or heterogeneous severe emphysema to improve quality of life, lung function, and exercise capacity.
PneumRx<sup>®</sup> Coils are small, shape-memory Nitinol implants, designed to gather and compress diseased tissue, re-tension the diseased airway network and mechanically increase the elastic recoil in the emphysematous lung.
The Coils have demonstrated safety and effectiveness in 5 European multi-centre studies. A national randomised, controlled study in France is pending data release this year. Enrollment for the FDA pivotal trial completed in 2014.5
The PneumRx® Coils are minimally invasive medical implants designed for the treatment of severe emphysema with hyperinflation.
If your patients with severe emphysema are experiencing worsening symptoms despite optimal medical treatment, they may be candidates for PneumRx® Coils.
The coils are designed to mechanically increase elastic recoil while simultaneously achieving lung volume.5
Arizona Patients Successfully Receive th...
Recommended Cash Offer for BTG plc by Bo...
BTG plc: Interim Results 2018